Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Immatics received early financing of $8.1M on 2004-02-11.
| Series | Round size | Date |
|---|---|---|
| Series A | $8M | 02/2004 |
| Series B | $41.7M | 02/2007 |
| Series C | $56.3M | 09/2010 |
| Series D | $12.5M | 10/2013 |
| Series D | $22.9M | 07/2014 |
| Series E | $30M | 01/2017 |
| Series E | $58M | 10/2017 |
| Series Unknown | $75M | 09/2019 |
| Post Ipo Equity | $104M | 03/2020 |
| Investors | Security type |
|---|---|
| EMBL Ventures GmbH | Series A |
| L-Bank | Series A |
| Merifin Capital | Series A |
| Grazia Equity | Series A |
| 3i PLC | Series A |
| VINCI CAPITAL | Series A |
| Wellington Partners | Series A |
| OH Beteiligungen | Series B |
| KfW | Series B |
| 3i PLC | Series B |
| SWISSCOM | Series B |
| DH Capital | Series B |
| Wellington Partners | Series B |
| NTEC | Series B |
| dievini Hopp Biotech Holding | Series C |
| MIG VERWALTUNGS AG | Series C |
| AT Impf | Series C |
| Wellington Partners | Series C |
| dievini Hopp Biotech Holding | Series D |
| AT Impf | Series D |
| Wellington Partners | Series D |
| dievini Hopp Biotech Holding | Series D |
| AT Impf | Series D |
| Wellington Partners | Series D |
| Grazia Equity | Series E |
| Amgen Inc. | Series E |
| dievini Hopp Biotech Holding | Series E |
| AT Impf | Series E |
| Wellington Partners | Series E |
| Amgen Inc. | Series E |
| CELGENE CORP /DE/ | Series Unknown |
| RTW INVESTMENTS LP | Post Ipo Equity |
| dievini Hopp Biotech Holding | Post Ipo Equity |
| Redmile Group | Post Ipo Equity |
| Sphera Funds Management | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| AT Impf | Post Ipo Equity |
| Wellington Partners | Post Ipo Equity |
Zippia gives an in-depth look into the details of Immatics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Immatics. The employee data is based on information from people who have self-reported their past or current employments at Immatics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Immatics. The data presented on this page does not represent the view of Immatics and its employees or that of Zippia.
Immatics may also be known as or be related to Immatics and Immatics Biotechnologies.